EORTC-CLTG

Program

Schedule
Focus
What´s new

Information in general

We aim to provide an all-encompassing conference where participants can present new research, exchange experiences, and engage in discussions about the latest advancements and emerging directions in the cross-disciplinary field of skin lymphoma, lymphoproliferative disorders, skin cancer, and both malignant and benign inflammation.

Schedule

10:30–18:00

REGISTRATION

12:15–13:30

WELCOME-LUNCH & POSTER VIEWING

13:30–14:15

CONGRESS OPENING

14:15–20:00

SCIENTIFIC PROGRAM

20:00–21:30

WELCOME RECEPTION

08:00–17:00

REGISTRATION

08:15–17:00

SCIENTIFIC PROGRAM

19:30–23:30

CONFERENCE DINNER (AT THE OLYMPIC MUSEUM)

08:00–14:00

REGISTRATION

09:15–14:30

SCIENTIFIC PROGRAM

14:30–15:30

PRIZE CEREMONY

Conference Focus

The conference will present sessions covering all aspects of cutaneous lymphomas

The CLTG Annual Meeting has evolved into the largest and most comprehensive conference globally, dedicated to the specific field where skin cancer meets inflammation – namely cutaneous lymphoma. International experts will present new data from clinical and preclinical studies, along with insights from clinical trials. Discussions will span the latest advancements in fundamental science, the establishment of high-priority research and development goals, addressing current challenges in patient care, and enhancing the treatment and management of skin lymphomas and their inflammatory counterparts.

Keynote and selected speakers will deliver overview presentations on scientific developments poised to play a pivotal role in this field in the near future. By the end of this conference, participants will be thoroughly updated in this specialized and complex field.

 

  • Pathophysiology, Genomics and Epigenomics, Molecular targets
  • Immunology, Host response, animal models, microenvironment
  • Translational research, diagnostic and prognostic markers
  • Pathology
  • Epidemiology
  • PROCLIPI research
  • New treatments, clinical trials, topical and systemic therapies, combination of treatments, therapeutic strategies
  • Quality of life and patient reported outcomes

WHAT´S NEW IN THE POSTER SESSIONS FORMAT

WHAT´S NEW IN THE POSTER SESSIONS FORMAT

Cultivating Understanding

Bridging the Divide Between Malignant and Benign Inflammation

Speed Clinic

Speeding Through the Uncommon: Clinical Case Sprint in Rare Disease

The Dilemma of the Erythema

Skin Lymphoma or Inflammatory Skin Disease Diagnostics

Speed Science

My Thesis in 180 Seconds

Thank you very much to our sponsors:

Abbvie
Abbvie